{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:53:34Z","timestamp":1779105214526,"version":"3.51.4"},"reference-count":51,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10,1]]},"DOI":"10.1210\/me.2009-0069","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T20:54:48Z","timestamp":1243544088000},"page":"1525-1531","source":"Crossref","is-referenced-by-count":74,"title":["Minireview: Live and Let Die: Molecular Effects of Glucocorticoids on Bone Cells"],"prefix":"10.1210","volume":"23","author":[{"given":"Lorenz C.","family":"Hofbauer","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine III, Technical University, Dresden and Center of Regenerative Therapies Dresden, D-01307 Dresden, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Rauner","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine III, Technical University, Dresden and Center of Regenerative Therapies Dresden, D-01307 Dresden, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2019041123323701300_R1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids.","volume":"96","author":"Scha\u0308cke","year":"2002","journal-title":"Pharmacol Ther"},{"key":"2019041123323701300_R2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1359\/jbmr.1999.14.7.1061","article-title":"New developments in the pathogenesis and treatment of steroid-induced osteoporosis.","volume":"14","author":"Manolagas","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2019041123323701300_R3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/ard.54.1.49","article-title":"Rheumatoid arthritis, corticosteroid therapy and hip fracture.","volume":"54","author":"Cooper","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"2019041123323701300_R4","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1001\/archinte.160.19.2917","article-title":"Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use.","volume":"160","author":"Naganathan","year":"2000","journal-title":"Arch Intern Med"},{"key":"2019041123323701300_R5","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.11283","article-title":"Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.","volume":"48","author":"Van Staa","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2019041123323701300_R6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/15419060802310208","article-title":"Role of gap junction, hemichannels, and connexin 43 in mineralizing in response to intermittent and continuous application of parathyroid hormone.","volume":"15","author":"Cherian","year":"2008","journal-title":"Cell Commun Adhes"},{"key":"2019041123323701300_R7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000098223","article-title":"Osteoimmunology.","volume":"143","author":"Rauner","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"2019041123323701300_R8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases.","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"key":"2019041123323701300_R9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.mce.2005.11.012","article-title":"Non-genomic glucocorticoid effects to provide the basis for new drug developments.","volume":"246","author":"Song","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"2019041123323701300_R10","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1359\/jbmr.2001.16.8.1496","article-title":"Colocalization of glucocorticoid and mineralocorticoid receptors in human bone.","volume":"16","author":"Beavan","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2019041123323701300_R11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mce.2007.05.014","article-title":"Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.","volume":"275","author":"Scha\u0308cke","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"2019041123323701300_R12","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1128\/MCB.01439-06","article-title":"Human glucocorticoid receptor \u03b2 binds RU-486 and is transcriptionally active.","volume":"27","author":"Lewis-Tuffin","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2019041123323701300_R13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0016-5085(00)70172-7","article-title":"Expression of glucocorticoid receptor \u03b2 in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis.","volume":"118","author":"Honda","year":"2000","journal-title":"Gastroenterology"},{"key":"2019041123323701300_R14","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0006-291X(02)02030-2","article-title":"Quantitative analysis for human glucocorticoid receptor \u03b1\/\u03b2 mRNA in IBD.","volume":"296","author":"Orii","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041123323701300_R15","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy.","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int"},{"key":"2019041123323701300_R16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650040202","article-title":"Bone histomorphometry in glucocorticoid-induced osteoporosis.","volume":"4","author":"Dempster","year":"1989","journal-title":"J Bone Miner Res"},{"key":"2019041123323701300_R17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041123323701300_R18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/me.2004-0212","article-title":"11\u03b2-Hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation.","volume":"19","author":"Eijken","year":"2005","journal-title":"Mol Endocrinol"},{"key":"2019041123323701300_R19","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1210\/en.2003-0655","article-title":"Transgenic expression of 11\u03b2-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone.","volume":"145","author":"Sher","year":"2004","journal-title":"Endocrinology"},{"key":"2019041123323701300_R20","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/(SICI)1097-4644(20000301)76:3<518::AID-JCB18>3.0.CO;2-M","article-title":"Tandem repeat of C\/EBP binding sites mediates PPAR\u03b32 gene transcription in glucocorticoid-induced adipocyte differentiation.","volume":"76","author":"Shi","year":"2000","journal-title":"J Cell Biochem"},{"key":"2019041123323701300_R21","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/1529-0131(199907)42:7<1405::AID-ANR14>3.0.CO;2-W","article-title":"Fat conversion of femoral marrow in glucocorticoid-treated patients: a cross-sectional and longitudinal study with magnetic resonance imaging.","volume":"42","author":"Vande Berg","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2019041123323701300_R22","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1074\/jbc.M704147200","article-title":"Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ).","volume":"283","author":"Zhang","year":"2008","journal-title":"J Biol Chem"},{"key":"2019041123323701300_R23","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1096\/fj.08-106302","article-title":"FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt\/\u03b2-catenin signaling-dependent Runx2 expression.","volume":"22","author":"Hamidouche","year":"2008","journal-title":"FASEB J"},{"key":"2019041123323701300_R24","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1210\/en.2007-0910","article-title":"Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss.","volume":"149","author":"Wang","year":"2008","journal-title":"Endocrinology"},{"key":"2019041123323701300_R25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1242\/dev.027706","article-title":"Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice.","volume":"136","author":"Zhou","year":"2009","journal-title":"Development"},{"key":"2019041123323701300_R26","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.23954","article-title":"Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization.","volume":"58","author":"Yao","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2019041123323701300_R27","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.lfs.2004.04.048","article-title":"Fas\/CD95 is associated with glucocorticoid-induced osteocyte apoptosis.","volume":"75","author":"Kogianni","year":"2004","journal-title":"Life Sci"},{"key":"2019041123323701300_R28","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength.","volume":"145","author":"O'Brien","year":"2004","journal-title":"Endocrinology"},{"key":"2019041123323701300_R29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jcp.21335","article-title":"Regulation of bim in glucocorticoid-mediated osteoblast apoptosis.","volume":"215","author":"Espina","year":"2008","journal-title":"J Cell Physiol"},{"key":"2019041123323701300_R30","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1359\/jbmr.080617","article-title":"Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo.","volume":"23","author":"Plotkin","year":"2008","journal-title":"J Bone Miner Res"},{"key":"2019041123323701300_R31","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1210\/en.2004-1414","article-title":"The antiarrhythmic peptide analog rotigaptide (ZP123) stimulates gap junction intercellular communication in human osteoblasts and prevents decrease in femoral trabecular bone strength in ovariectomized rats.","volume":"146","author":"J\u00f8rgensen","year":"2005","journal-title":"Endocrinology"},{"key":"2019041123323701300_R32","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis.","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"2019041123323701300_R33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jcb.21414","article-title":"Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels.","volume":"103","author":"Kondo","year":"2008","journal-title":"J Cell Biochem"},{"key":"2019041123323701300_R34","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/art.24445","article-title":"Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL.","volume":"60","author":"Hofbauer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2019041123323701300_R35","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/en.2006-0459","article-title":"Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density.","volume":"147","author":"Jia","year":"2006","journal-title":"Endocrinology"},{"key":"2019041123323701300_R36","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI28084","article-title":"Glucocorticoids suppress bone formation via the osteoclast.","volume":"116","author":"Kim","year":"2006","journal-title":"J Clin Invest"},{"key":"2019041123323701300_R37","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.","volume":"25","author":"Tomlinson","year":"2004","journal-title":"Endocr Rev"},{"key":"2019041123323701300_R38","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1210\/jc.2002-020970","article-title":"11\u03b2-Hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.","volume":"87","author":"Diederich","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041123323701300_R39","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1210\/me.2002-0355","article-title":"A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects.","volume":"17","author":"Coghlan","year":"2003","journal-title":"Mol Endocrinol"},{"key":"2019041123323701300_R40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.0300372101","article-title":"Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.","volume":"101","author":"Scha\u0308cke","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041123323701300_R41","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.bone.2005.10.004","article-title":"Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.","volume":"38","author":"Humphrey","year":"2006","journal-title":"Bone"},{"key":"2019041123323701300_R42","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.mce.2006.11.006","article-title":"The growth plate sparing effects of the selective glucocorticoid receptor modulator, AL-438.","volume":"264","author":"Owen","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"2019041123323701300_R43","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1016\/j.bmcl.2007.07.031","article-title":"Identification of dissociated non-steroidal glucocorticoid receptor agonists.","volume":"17","author":"Kuzmich","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"2019041123323701300_R44","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.4049\/jimmunol.180.4.2608","article-title":"A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis.","volume":"180","author":"Dewint","year":"2008","journal-title":"J Immunol"},{"key":"2019041123323701300_R45","doi-asserted-by":"crossref","first-page":"15827","DOI":"10.1073\/pnas.0505554102","article-title":"A fully dissociated compound of plant origin for inflammatory gene repression.","volume":"102","author":"De Bosscher","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041123323701300_R46","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.bmcl.2005.02.009","article-title":"Novel heterocyclic glucocorticoids: in vitro profile and in vivo efficacy.","volume":"15","author":"Thompson","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"2019041123323701300_R47","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1016\/j.bmcl.2004.07.052","article-title":"Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands.","volume":"14","author":"Shah","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"2019041123323701300_R48","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1016\/j.bmcl.2005.03.027","article-title":"Novel ketal ligands for the glucocorticoid receptor: in vitro and in vivo activity.","volume":"15","author":"Smith","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"2019041123323701300_R49","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1021\/jm060302x","article-title":"Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series.","volume":"49","author":"Barker","year":"2006","journal-title":"J Med Chem"},{"key":"2019041123323701300_R50","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1210\/en.2007-1353","article-title":"LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo.","volume":"149","author":"Lo\u0301pez","year":"2008","journal-title":"Endocrinology"},{"key":"2019041123323701300_R51","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.4049\/jimmunol.166.3.1975","article-title":"Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity.","volume":"166","author":"Belvisi","year":"2001","journal-title":"J Immunol"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/23\/10\/1525\/9245404\/mend1525.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T14:32:26Z","timestamp":1555079546000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/23\/10\/1525\/2870394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,1]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2009-0069","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,1]]}}}